logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-39. Treatment prevalence in 2006 in nine countries: percentage distribution of all treatment clients by primary drug at treatment entry (first treatment incidence, total treatment incidence, total treatment prevalence)

CountryCannabisCocaineOpioidsStimulants
FTITTITRPFTITTITRPFTITTITRPFTITTITRP
Bulgaria(1)7.70.00.80.00.10.185.596.798.46.81.40.7
Bulgaria(2)1.10.60.60.00.20.298.399.099.00.00.00.0
Czech Republic(3)18.412.512.50.10.10.116.725.525.562.159.159.1
Italy(1)18.415.710.228.524.817.349.656.769.80.60.60.5
Latvia(1)10.88.70.50.441.058.926.815.8
Hungary(1)68.453.51.71.66.615.49.79.2
Hungary(2)5.44.40.80.610.114.19.17.3
Malta(4)18.911.87.411.78.45.963.876.284.54.52.71.7
Netherlands(3)43.331.820.431.634.729.910.522.341.39.57.55.0
Austria(1)37.825.626.37.26.46.547.960.760.14.94.04.1
Austria(2)9.47.68.98.86.16.875.479.376.61.21.92.2
France(1)53.337.342.86.16.85.832.746.044.11.91.71.2
Total percentage25.518.316.322.320.915.638.949.859.37.68.23.8
Total clients1355813765423221187015771406152069337502154192403461619837

Notes:

 FTI: First treatment incidence = first treatments in life. 

 TTI: Total treatment incidence = first treatments in life + repeated treatments. 

 TRP: Total prevalence = first treatments in life + repeated treatments + continuous treatments. 

                    

 Data refer to 2006, except for France (2005). 

 Percentages are based on case totals excluding the cases with missing information. 

 Countries reporting data are: AT, BG, CZ, FR, IT, LV, HU, MT and NL .  

 FTL data are not available for Latvia and the Netherlands and AST are not available for Latvia, Hungary and Malta. 

 (1) Data refer to outpatient treatment units.  

 (2) Data refer to inpatient treatment units. 

 (3) Data from the Czech Republic refer to outpatient and inpatient treatment units and low-threshold agencies.  

 (4) Data refer to outpatient and inpatient treatment units and treatment units in prisons. 

Sources:

 2007 Pilot data collection on treatment prevalence. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008